Foto del docente

Pier Paolo Piccaluga

Professore associato

Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale

Settore scientifico disciplinare: MED/08 ANATOMIA PATOLOGICA

Pubblicazioni

PICCALUGA PP; LUATTI S; ASCANI S; BIANCHINI M; MALAGOLA M; RONDONI M; GAITANI S; TESTONI N.; PILERI SA; BACCARANI M; MARTINELLI G; VISANI G, Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia, «CANCER GENETICS AND CYTOGENETICS», 2004, 151 (1), pp. 85 - 86 [articolo]

Pileri S.A.; Dirnhofer S.; Sabattini E.; Piccaluga P.P.; Bacci F.; Agostinelli C.; Bodega L.; Orduz R.; Falini B.; Zinzani P.L., Identification of outcome predictors in diffuse large B-cell lymphoma. of homogeneously treated de novo nodal tumours on tissue micro-arrays., in: Abstract Book, S.N., s.n, 2004, pp. 45 - 45 (atti di: XII Meeting of the Euroepan Association for Haematopathology., Thessaloniki, GR,, Septemebr 26-October 1, 2004.) [atti di convegno-abstract]

Piccaluga PP; Ricci P; Malagola M; Rondoni M; Vigna E; Bosi C; Gaitani S; Visani G; Martinelli G., Instillazione diretta intranasale di amfotericina B liposomiale nella terapia delle micosi nasali., «FARMACI», 2004, 27(3), pp. 13 - 15 [articolo]

Visani G; Malagola M; Piccaluga PP; Isidori A., Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?, «LEUKEMIA & LYMPHOMA», 2004, 45, pp. 1531 - 1538 [articolo]

Piccaluga, Pier Paolo; Martinelli, Giovanni; Rondoni, Michela; Malagola, Michele; Ronconi, Sonia; Visani, Giuseppe; Baccarani, Michele, Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly, «HAEMATOLOGICA», 2004, 88, pp. ECR37 - 37 [articolo]Open Access

MARTINELLI G; RONDONI M; BUONAMICI S; OTTAVIANI E; PICCALUGA PP; MALAGOLA M; BACCARANI M., Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely., «HAEMATOLOGICA», 2004, 89, pp. 495 - 497 [articolo]

VISANI G; ISIDORI A; GRAFONE T; TOSI P; SANTINI V; MALAGOLA M; MARTINELLI G.; PICCALUGA PP; GRAZIEV D; OTTAVIANI E; SPARAVENTI G; TURA S., No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?, «LEUKEMIA & LYMPHOMA», 2004, 45(7), pp. 1361 - 1364 [articolo]

Pileri S.A.; Piccaluga P.P.; Agostinelli C.; Sabattini E.; Bacci F.; Orduz R.; Righi S.; Sandri F.; Falini B.; Zinzani P.L.; Gallamini A.; Dalla Favera R., Peripheral T-cell lymphoma. A still uncurable disease?, in: Ten Years After the REAL Classification: Open Issues, 2004, 89 (suppl 9), pp. 62 - 65 (atti di: Ten Years After the REAL Classification: Open Issues, Bologna, Italia, October 6–9, 2004.) [Contributo in Atti di convegno]

PICCALUGA PP; RICCI P; MARTINELLI G.; MALAGOLA M; RONDONI M; VISANI G., Prompt resolution of nasal aspergillosis with intranasal instillation of liposomal amphotericin-B (amBisome) and granulocyte transfusions, «LEUKEMIA & LYMPHOMA», 2004, 45(3), pp. 637 - 638 [articolo]

MALAGOLA M; MARTINELLI G.; RONDONI M; OTTAVIANI E; PICCALUGA PP; RICCI P; VISANI G; BACCARANI M., Soft tissue and skeletal involvement in FIP1L1-PDGFR-A positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission, «HAEMATOLOGICA», 2004, 89, pp. 85 - 86 [articolo]Open Access

PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M.; MARTINELLI G., The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients., «HAEMATOLOGICA», 2004, 80, pp. 1269 - 1271 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.